Clinical Trial Update: Intraoperative Low-dose Ketamine Infusion for Patients With Obstructive Sleep Apnea [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial evaluating intraoperative low-dose ketamine infusion in patients with obstructive sleep apnea (OSA) was terminated with posted result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea
• Postoperative Complications
• Sleep Apnea

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Sleep Apnea, Obstructive Sleep Apnea | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2019-12-19